Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mercedes Romano Rodriguez"'
Autor:
Benedikt Fritzsching, Marco Contoli, Celeste Porsbjerg, Sarah Buchs, Julie Rask Larsen, Lisa Elliott, Mercedes Romano Rodriguez, Nick Freemantle
Publikováno v:
The Lancet Regional Health. Europe, Vol 13, Iss , Pp 100275- (2022)
Summary: Background: Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence from randomised controlled trials (RCTs). Methods: REACT (
Externí odkaz:
https://doaj.org/article/a6b5c685a2174bc59d4c97bcccb513a1
Autor:
Celeste Porsbjerg, Benedikt Fritzsching, Marco Contoli, Mercedes Romano Rodriguez, Lisa Elliott, Sarah Buchs, Julie Rask Larsen, Nick Freemantle
Publikováno v:
The Lancet Regional Health-Europe
Fritzsching, B, Contoli, M, Porsbjerg, C, Buchs, S, Larsen, J R, Elliott, L, Rodriguez, M R & Freemantle, N 2022, ' Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma : Results from the REACT study, a retrospective cohort study. ', The Lancet Regional Health-Europe, vol. 13, 100275 . https://doi.org/10.1016/j.lanepe.2021.100275
The Lancet Regional Health. Europe, Vol 13, Iss, Pp 100275-(2022)
Fritzsching, B, Contoli, M, Porsbjerg, C, Buchs, S, Larsen, J R, Elliott, L, Rodriguez, M R & Freemantle, N 2022, ' Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma : Results from the REACT study, a retrospective cohort study. ', The Lancet Regional Health-Europe, vol. 13, 100275 . https://doi.org/10.1016/j.lanepe.2021.100275
The Lancet Regional Health. Europe, Vol 13, Iss, Pp 100275-(2022)
Background: Allergen immunotherapy (AIT) is the only causal treatment for respiratory allergy. Long-term real-life effectiveness of AIT remains to be demonstrated beyond the evidence from randomised controlled trials (RCTs). Methods: REACT (Real worl
Publikováno v:
Quality of Life Research. 27:2383-2391
Purpose\ud Allergic rhinitis and asthma symptoms are detrimental to health-related quality of life (HRQoL). Health technology appraisal agencies often require cost–utility analysis when assessing new interventions. Appropriate utility estimates, wh
Autor:
Eva Martínez Moragón, Carlos Miñarro, Emma Martínez Savoini, Ernesto Enrique Miranda, Adolfo Galan Vivo, Inmaculada Sánchez-Guerrero Villajos, Christian Domingo Ribas, Mercedes Romano Rodriguez
Publikováno v:
Ethics and economics.
Introduction: 12SQ HDM SLIT-tablet (Acarizax®) is an oral lyophilisate house dust mite (HDM) standardised allergen extract, indicated for HDM allergic rhinitis and asthma, that has proved a reduction in time to first moderate/severe asthma exacerbat